linsidomine has been researched along with Alloxan Diabetes in 2 studies
linsidomine: RN given refers to parent cpd; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tasatargil, A | 1 |
| Sadan, G | 1 |
| González, E | 1 |
| Jawerbaum, A | 1 |
| Sinner, D | 1 |
| Pustovrh, C | 1 |
| Xaus, C | 1 |
| Peralta, C | 1 |
| Gómez, G | 1 |
| Roselló-Catafau, J | 1 |
| Gelpi, E | 1 |
| Gimeno, M | 1 |
2 other studies available for linsidomine and Alloxan Diabetes
| Article | Year |
|---|---|
Reduction in [D-Ala2, NMePhe4, Gly-ol5]enkephalin-induced peripheral antinociception in diabetic rats: the role of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway.
Topics: Analgesics, Opioid; Animals; Arginine; Blood Glucose; Cyclic GMP; Diabetes Mellitus, Experimental; D | 2004 |
Evolution of streptozotocin-pancreatic damage in the rat: modulatory effect of endothelins on the nitridergic and prostanoid pathway.
Topics: Animals; Arachidonic Acid; Diabetes Mellitus, Experimental; Dinoprost; Dinoprostone; Endothelin-1; E | 1999 |